The Latest Breaking News from Cancer

Shares of bioAffinity Technologies Inc. (NASDAQ: BIAF) are trading higher Friday after the biotech company released case studies affirming the performance of one of its products. The Texas-based company builds non-invasive diagnostics for lung cancer.

The longtime assistant is in his first year with New England.

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: SNY) Genzyme Corporation.

Removing lymph nodes during cancer surgery has saved countless lives in many tumour types. Yet recent research is challenging parts of this long-standing practice.

Pakistan's health minister says the country has vaccinated about 9 million adolescent girls against the virus that causes cervical cancer, as part of a continuing national campaign that has overcome early setbacks fueled by skeptics online

On Thursday, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Co.’s (NYSE: LLY) Inluriyo (imlunestrant) for adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2–), ESR1-mutated advanced or metastatic breast cancer (MBC) whose disease progressed after at least one line of endocrine therapy (ET).

Polychlorinated biphenyls, or PCBs, a class of fire-resistant industrial chemicals, were widely used in electrical transformers, oils, paints and even building materials throughout the 20th century. However, once scientists learned PCBs were accumulating in the environment and posed a cancer risk to humans, new PCB production was banned in the…

This is an honorable statement from Sheepsticked against cancer.

The Prince of Wales opens up to ‘Schitt’s Creek’ co-creator Eugene Levy as part of an upcoming travel series

IN FULL

One in 10 have never checked, the survey suggests.